Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaim Putterman

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Journal of Autoimmunity|September 4, 2018
Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupusElise V Mike, Hadijat M Makinde, Maria Gulinello, et al.
The Journal of Investigative Dermatology|April 1, 2015
TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous LupusJessica L Doerner, Jing Wen, Yumin Xia, et al.
Arthritis Research & Therapy|September 30, 2009
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort studyNoa Schwartz, Tamar Rubinstein, Linda C Burkly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus ErythematosusRosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, et al.
Rheumatology (Oxford, England)|June 7, 2018
The SLE-key test serological signature: new insights into the course of lupusChaim Putterman, David S Pisetsky, Michelle Petri, et al.
ACR Open Rheumatology|February 4, 2021
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified LupusRosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, et al.
Arthritis Research & Therapy|January 27, 2018
Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupusSamantha A Chalmers, Jing Wen, Jessica Doerner, et al.
Arthritis and Rheumatism|November 16, 2011
Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in miceRahul D Pawar, Milena Pitashny, Simona Gindea, et al.
Journal of Autoimmunity|June 14, 2015
Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritisGuillaume Seret, Felipe Cañas, Laurence Pougnet-Di Costanzo, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Journal of Autoimmunity|September 4, 2018
Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupusElise V Mike, Hadijat M Makinde, Maria Gulinello, et al.
The Journal of Investigative Dermatology|April 1, 2015
TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous LupusJessica L Doerner, Jing Wen, Yumin Xia, et al.
Arthritis Research & Therapy|September 30, 2009
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort studyNoa Schwartz, Tamar Rubinstein, Linda C Burkly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus ErythematosusRosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, et al.
Rheumatology (Oxford, England)|June 7, 2018
The SLE-key test serological signature: new insights into the course of lupusChaim Putterman, David S Pisetsky, Michelle Petri, et al.
ACR Open Rheumatology|February 4, 2021
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified LupusRosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, et al.
Arthritis Research & Therapy|January 27, 2018
Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupusSamantha A Chalmers, Jing Wen, Jessica Doerner, et al.
Arthritis and Rheumatism|November 16, 2011
Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in miceRahul D Pawar, Milena Pitashny, Simona Gindea, et al.
Journal of Autoimmunity|June 14, 2015
Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritisGuillaume Seret, Felipe Cañas, Laurence Pougnet-Di Costanzo, et al.
Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.
Pageof 21